Skip to Content
Merck
CN

T2629

Sigma-Aldrich

Sodium tungstate dihydrate

suitable for preparation of protein-free filtrates according to Folin

Synonym(s):

Tungstic acid sodium salt dihydrate

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

Linear Formula:
Na2WO4 · 2H2O
CAS Number:
10213-10-2
Molecular Weight:
329.85
EC Number:
236-743-4
MDL number:
MFCD00149190
UNSPSC Code:
12352302
PubChem Substance ID:
329826718
NACRES:
NA.55
Form:
powder

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

form

powder

reaction suitability

reagent type: catalyst
core: tungsten

pH

9-11.5 (20 °C, 100 g/L)

mp

698 °C (lit.)

suitability

suitable for preparation of protein-free filtrates according to Folin

SMILES string

O.O.[Na+].[Na+].[O-][W]([O-])(=O)=O

InChI

1S/2Na.2H2O.4O.W/h;;2*1H2;;;;;/q2*+1;;;;;2*-1;

InChI key

WPZFLQRLSGVIAA-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302

Precautionary Statements

P264 - P270 - P301 + P312 - P501

Hazard Classifications

Acute Tox. 4 Oral

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKBT5611V
SLBC2757V
080M1618V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

F Hanzu et al.
Diabetes, obesity & metabolism, 12(11), 1013-1018 (2010-10-01)
Considering the poor long-term success of current dietary and pharmacological interventions, we aimed to evaluate the potential effect of sodium tungstate in the treatment of grade I and II obesity (ClinicalTrials.gov identifier: NCT00555074). Prospective, randomized, placebo-controlled, double-blind, proof-of-concept study was
C J Rodriguez-Hernandez et al.
FEBS letters, 586(3), 270-276 (2012-01-17)
Tungstate counteracts diabetes and obesity in animal models, but its molecular mechanisms remain elusive. Our Saccharomyces cerevisiae-based approach has found that tungstate alleviated the growth defect induced by nutrient stress and enhanced the activation of the GCN pathway. Tungstate relieved
M Amigó-Correig et al.
Diabetes, obesity & metabolism, 13(3), 235-242 (2011-01-06)
Sodium tungstate is an anti-obesity drug targeting peripheral tissues. In vivo, sodium tungstate reduces body weight gain and food intake through increasing energy expenditure and lipid oxidation, but it also modulates hypothalamic gene expression when orally administered, raising the possibility
Andrew R Osterburg et al.
Journal of immunotoxicology, 7(3), 174-182 (2010-02-25)
The potential for adverse health effects of using tungsten and its alloys in military munitions are an important concern to both civilians and the US military. The toxicological implications of exposure to tungsten, its alloys, and the soluble tungstate (Na(2)WO(4))
Delia Zafra et al.
FEBS letters, 587(3), 291-296 (2012-12-25)
Tungstate treatment ameliorates experimental diabetes by increasing liver glycogen deposition through an as yet unidentified mechanism. The signalling mechanism of tungstate was studied in CHOIR cells and primary cultured hepatocytes. This compound exerted its pro-glycogenic effects through a new G-protein-dependent
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service